Newsletter subscription & archive

Are you a interested in patient advocacy? The next EUPATI expert training course is open for enrolment

09-10-2019

The European Patients’ Academy (EUPATI) is a pan-European project implemented as a public-private partnership by a collaborative multi-stakeholder consortium from the pharmaceutical industry, academia, not-for-profit, anThe more involved a patient is in their healthcare, the better their health outcomes!

The next 14-month EUPATI training course for patient advocates not skilled in medicines development begins October 2020. Application deadline is 28 October 2019.

Applicants may be either be an employee or volunteer of a patient organisation, a patient with a chronic and/or lifelong illness/condition who is not affiliated with a patient organisation and/or a family member/carer (not affiliated with a patient organisation) of a patient with a chronic and/or lifelong illness/condition.

250 hours commitment
Applicants must be able to commit to a total of 250 hours at minimum to study the online lessons, actively participate in the online forum discussions during the entire duration of the course, and to attend the full programme of the two face-to-face training sessions, with each lasting 5 days. The online lessons and their online assessments will be available in English only.The two face-to-face sessions will require a high level of interaction and communication in English.

The training course
The training course is a 14-month course for laypeople on medicines research and development. It's a mixture of independent e-learning coursework and face-to-face training events. By the end of the course, students will to be able to make a meaningful contribution to the medical community in their task of providing better medicines to patients and to generate broader dialogue around future patient involvement in medicines R&D throughout Europe.

The course modules include

  • Discovery of Medicines & Planning of Medicines Development
  • Non-Clinical testing and pharmaceutical development
  • Exploratory and confirmatory clinical development
  • Clinical trials
  • Regulatory Affairs
  • Medicinal product safety
  • Pharmacovigilance and pharmacoepidemiology
  • Health technology assessment principles and practices

Outcome
Having completed the EUPATI training course, patient advocates will have the knowledge to make a meaningful contribution to the medicines research and development process to provide better medicines. They will furthermore be able to generate a broader dialogue around future patient involvement in the medicines research and development process across Europe.

About EUPATI
The European Patients’ Academy (EUPATI) was first created in 2012 with the intention of producing reliable information for patients and their advocates on the medicine research and development (R&D) process. An IMI initiative, one of EUPATI's activities is to run training courses for lay people to apply expert-level knowledge across the entire spectrum of medicine R&D. The first course cycle kicked off in October 2014 and ran until December 2015. The second course started in September 2015 and ended in November 2016. The third expert patient course 56 participants ended in 2018 with the last graduates finishing in December. The fourth course is currently recruiting, applications can be submitted until 28 October 2019.

Deadline for applications: 28 October 2019, 13:00

Read more about EUPATI

Apply now on the EUPATI website

Guide for applicants - read here

BIopeople contact: Per Spindler

CloseClose
What are you looking for?